Rexulti generic date?

See the DrugPatentWatch profile for Rexulti

When will a generic Rexulti (brexpiprazole) be available?

“Rexulti” is the brand name for brexpiprazole. Generic availability depends on when relevant patents and exclusivity end for brexpiprazole.

Why does the generic date vary depending on patents and exclusivity?

Even if a company files for approval, it generally can’t launch a generic until it clears patent barriers and any granted exclusivities expire. That’s why “generic date” results often differ by source (they may reflect patent expiry, exclusivity expiry, or expected “first generic launch” timing).

What to check for the most accurate “generic Rexulti date”?

DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and typically provides the key dates that determine when generics can enter. You can look up Rexulti/brexpiprazole here:
https://www.drugpatentwatch.com/

Who can sell a generic first (and what determines the launch date)?

The first generic or interchangeable product usually launches only after it is legally allowed to do so. That timing is driven by:
- patent expiry/expiration dates for brexpiprazole
- any applicable regulatory exclusivities
- whether other market-entry barriers (such as settlements or ongoing patent litigation) delay launch

If you tell me your country, can I narrow the date?

Generic timing can differ by country (US vs. EU vs. UK vs. other markets). If you share the country you care about, I can help interpret the most relevant patent/exclusivity dates for that market.